59 episodes

"The Long Run"

Antarctic explorer Ernest Shackleton, if he were alive, would appreciate biotech. Today’s scientific entrepreneurs must be ready for the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina, and resilience, to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

The Long Run with Luke Timmerman HeadStepper Media

    • Science

"The Long Run"

Antarctic explorer Ernest Shackleton, if he were alive, would appreciate biotech. Today’s scientific entrepreneurs must be ready for the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina, and resilience, to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

    Ep61: Sanjiv Patel

    Ep61: Sanjiv Patel

    Sanjiv Patel, CEO of Relay Therapeutics, computational drug discovery company.

    • 1 hr 5 min
    Ep60: Tim Mayleben

    Ep60: Tim Mayleben

    Tim Mayleben, CEO of Esperion Therapeutics, on cholesterol-lowering meds.

    • 1 hr 9 min
    Ep59: David Baker

    Ep59: David Baker

    David Baker, University of Washington protein designer.

    • 1 hr 1 min
    Ep58: Jigar Raythatha

    Ep58: Jigar Raythatha

    Jigar Raythatha of Constellation Pharma on epigenetic drug development.

    • 1 hr 11 min
    Ep57: John Alam

    Ep57: John Alam

    John Alam on Alzheimer's drug development.

    • 1 hr 20 min
    Ep56: Tim Springer

    Ep56: Tim Springer

    Tim Springer of Harvard Medical School on his career in science and biotech.

    • 1 hr 5 min

Customer Reviews

D Howell BondwellTech ,

Great Podcast!

I never miss and episode. Would love to see you get one of the Incept founders on. Fred Khosravi and Amar Sawhney have a unique business model and would be a great interview for Luke.

yul51471 ,

Interesting guests—give them the spotlight

Lots of interesting and unique perspectives here—would suggest that Luke talk/ramble less and focus on the interviewee. At times it feels like Luke imposes his views/input on the guest which takes away from the story.

Keermaster ,

A needle in the haystack of biotechnology

A great listen for anyone who is going into industry or is an investor in biotech. I would love to see more episodes of deans of biotech grad schools to understand their point of view as well. Thank you, Luke!

Top Podcasts In Science

Listeners Also Subscribed To

More by HeadStepper Media